Pharma majors banking on India, other emerging markets for growth: Report

December 2008
Chemical Business;Dec2008, Vol. 22 Issue 12, p46
Trade Publication
The article reports on the findings of a global survey of top pharmaceutical companies conducted by Ernst & Young regarding the success of pharmaceutical firms in emerging markets. The survey found that global drug firms are depending on these markets to extend the life of their mature products and to develop new markets for their ethical products.


Related Articles

  • Pharma CFOs key to driving growth: E&Y.  // Chemical Business;Apr2008, Vol. 22 Issue 4, p92 

    The article reports on the findings of a survey conducted by global consultancy company Ernst & Young (E&Y), which state that the role of chief financial officers (CFOs) in the pharmaceutical sector in India is undergoing a change and they will have to be more proactive than before as firms seek...

  • Ernst & Young survey finds counterfeiting fight is a priority.  // Long Island Business News (7/1993 to 5/2009);5/13/2005, Vol. 52 Issue 20, p8B 

    Reports that many pharmaceutical companies are taking steps to better control the distribution of drugs, cutting off suppliers that violate contracts and tapping technology to battle counterfeiting according to a study by Ernst and Young in the U.S. Percentage of pharmaceutical firms that...

  • Survey: Outsourcing Considered by Pharma. Gaudio, Thomas // njbiz;3/31/2008, Vol. 21 Issue 14, p2 

    The article reports on the findings of a survey by Ernst & Young which revealed that pharmaceutical firms are more likely to consider outsourcing to cut costs than executives from other industries. The survey found that 64 percent of chief-level and board-level executives at worldwide drug...

  • FRAUD-FIGHTING COMMITMENT WAVERING. McCollum, T. // Internal Auditor;Aug2012, Vol. 69 Issue 4, p13 

    The article reports on the willingness of some managers to commit fraud according to the results of the 2012 Global Fraud Survey conducted by Ernst & Young (E&Y).

  • New Study Reveals Lack of Full Health Reform Planning. Ladd, Scott // Financial Executive;Jan2011, Vol. 27 Issue 1, p9 

    The article looks at the new survey by Ernst & Young LLP which revealed that many executives are not aware of the national health care reform and its potential impact on their companies.

  • IPOS ON THE RISE.  // Smart Business South Florida;May2010, Vol. 2 Issue 4, p10 

    The article reports on result of the survey conducted by Ernst & Young LLP that analyzes the business activity among Russell 2000 companies which reveals that many firms are on the growth path.

  • Are You Ready for a Second Brain Drain?  // Toledo Business Journal;Mar2014, Vol. 30 Issue 3, p13 

    The article focuses on Ernst & Young LLP survey of Fortune 1000 companies showing that 62% of employers believe future retirements will result in a labor shortage, wherein with every passing year there will be lesser number of workers with the knowledge and experience to lead effectively

  • Drug resistance of the fighting fit.  // EG: Estates Gazette;10/25/2003, Issue 343, Special section p16 

    Focuses on the condition of the European pharmaceutical industry as of October 2003. Percentage accounted by the sector for all inward investment projects into Europe in 2002, according to research by Ernst & Young; Key features of pharmaceutical investment in 2002; Competition between the U.S....

  • A tough balancing act.  // Banker Middle East;Feb2012, Issue 137, p38 

    The article discusses about the role of chief financial officers (CFOs) in balancing investments and managing risk in diverse markets, focusing on a survey from professional services company Ernst & Young. Topics include balancing resource allocation between rapid-growth and developed markets,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics